A groundbreaking 14-year Chinese study of over 48,000 HIV-positive patients yields three essential findings for healthcare providers and policymakers. First, recurrent STI infections affect 40% of HIV-positive patients, demonstrating that single-treatment approaches are insufficient for managing co-infections. Second, bacterial STIs—particularly gonorrhea and chlamydia—showed sharp resurgence after 2018, reversing earlier declining trends and signaling the need for renewed surveillance and intervention efforts.
Most significantly, the research demonstrates that systematic STI screening outperforms symptom-based testing by 23%, meaning proactive surveillance protocols are essential for identifying infections that patients may not recognize or report. This finding has direct implications for HIV care program design and resource allocation.
Led by the National Center for AIDS/STD Control and Prevention and published in The Lancet Regional Health – Western Pacific, this study provides evidence-based guidance for strengthening integrated HIV-STI prevention strategies. Healthcare systems should prioritize routine screening protocols, enhanced bacterial infection surveillance post-2018, and comprehensive patient education about co-infection risks.
Read the full article on GMJ Newsroom.
Was this article helpful?
